ORIGINAL RESEARCH

Testing for Human Immunodeficiency Virus Among Cancer Survivors Under Age 65 in the United States

Age	Predicted Probability of HIV Test (95% CI)
18	0.36 (0.26–0.48)
19	0.37 (0.27–0.47)
20	0.37 (0.27–0.47)
21	0.37 (0.28–0.47)
22	0.37 (0.29–0.46)
23	0.37 (0.29–0.46)
24	0.37 (0.30–0.46)
25	0.37 (0.30–0.45)
26	0.38 (0.31–0.45)
27	0.38 (0.31–0.45)
28	0.38 (0.32–0.45)
29	0.38 (0.32–0.44)
30	0.38 (0.33–0.44)
31	0.38 (0.33–0.44)
32	0.39 (0.33–0.44)
33	0.39 (0.34–0.44)
34	0.39 (0.34–0.44)
35	0.39 (0.34–0.44)
36	0.38 (0.34–0.43)
37	0.38 (0.34–0.43)
38	0.38 (0.33–0.43)
39	0.37 (0.33–0.42)
40	0.37 (0.32–0.41)
41	0.36 (0.32–0.41)
42	0.35 (0.31–0.40)
43	0.34 (0.30–0.39)
44	0.33 (0.29–0.37)
45	0.31 (0.27–0.36)
46	0.30 (0.26–0.34)
47	0.28 (0.24–0.32)
48	0.26 (0.23–0.32)
49	0.24 (0.21–0.28)
50	0.22 (0.19–0.26)
51	0.20 (0.18–0.24)
52	0.18 (0.16–0.21)
53	0.17 (0.14–0.20)
54	0.15 (0.13–0.18)
55	0.14 (0.12–0.16)
56	0.13 (0.11–0.15)
57	0.12 (0.10–0.14)
58	0.11 (0.09–0.13)
59	0.11 (0.09–0.13)
60	0.10 (0.09–0.12)
61	0.10 (0.08–0.12)
62	0.10 (0.08–0.12)
63	0.09 (0.08–0.11)
64	0.09 (0.07–0.11)

Figure 1. Model-adjusted relationship between age and human immunodeficiency virus (HIV) testing among cancer survivors aged 18 to 64 years, United States, 2009, Behavioral Risk Factor Surveillance System. Abbreviation: CI, confidence interval.

Return to article

 

Age	Predicted Probability of HIV Test (95% CI)
0	0.15 (0.12–0.18)
1	0.15 (0.13–0.18)
2	0.16 (0.13–0.18)
3	0.16 (0.13–0.19)
4	0.16 (0.14–0.19)
5	0.16 (0.14–0.19)
6	0.17 (0.14–0.19)
7	0.17 (0.14–0.20)
8	0.17 (0.14–0.20)
9	0.17 (0.14–0.20)
10	0.17 (0.15–0.20)
11	0.17 (0.15–0.20)
12	0.17 (0.15–0.20)
13	0.17 (0.15–0.20)
14	0.17 (0.15–0.20)
15	0.17 (0.15–0.20)
16	0.17 (0.14–0.20)
17	0.17 (0.14–0.20)
18	0.17 (0.14–0.20)
19	0.17 (0.14–0.20)
20	0.17 (0.14–0.20)
21	0.17 (0.14–0.19)
22	0.16 (0.14–0.19)
23	0.16 (0.14–0.19)
24	0.16 (0.14–0.19)
25	0.16 (0.13–0.19)
26	0.16 (0.13–0.19)
27	0.16 (0.13–0.19)
28	0.16 (0.13–0.19)
29	0.15 (0.13–0.18)
30	0.15 (0.13–0.18)
31	0.15 (0.12–0.18)
32	0.15 (0.12–0.18)
33	0.15 (0.12–0.18)
34	0.15 (0.12–0.18)
35	0.15 (0.12–0.18)
36	0.14 (0.11–0.18)
37	0.14 (0.11–0.18)
38	0.14 (0.11–0.18)
39	0.14 (0.11–0.18)
40	0.14 (0.11–0.18)
41	0.14 (0.10–0.18)
42	0.14 (0.10–0.18)
43	0.13 (0.10–0.18)
44	0.13 (0.10–0.18)
45	0.13 (0.10–0.18)
46	0.13 (0.10–0.18)
47	0.13 (0.09–0.18)
48	0.13 (0.09–0.18)
49	0.13 (0.09–0.18)
50	0.13 (0.09–0.18)
51	0.12 (0.09–0.17)
53	0.12 (0.08–0.17)
54	0.12 (0.08–0.17)
55	0.12 (0.08–0.17)
56	0.12 (0.08–0.17)
57	0.12 (0.08–0.17)
58	0.12 (0.08–0.17)
59	0.12 (0.08–0.17)
62	0.11 (0.07–0.17)
63	0.11 (0.07–0.17)

Figure 2. Model-adjusted relationship between age and human immunodeficiency virus (HIV) testing among cancer survivors aged 18 to 64 years, United States, 2009, Behavioral Risk Factor Surveillance System. Abbreviation: CI, confidence interval.

Return to article

---

The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions.